Rituximab treatment for adult patients with focal segmental glomerulosclerosis.

MLA

Ochi, Ayami, et al. “Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis.” Internal Medicine (Tokyo, Japan), vol. 51, no. 7, 2012, pp. 759–62. EBSCOhost, https://doi.org/10.2169/internalmedicine.51.6854.

APA

Ochi, A., Takei, T., Nakayama, K., Iwasaki, C., Kamei, D., Tsuruta, Y., Shimizu, A., Shiohira, S., Moriyama, T., Itabashi, M., Mochizuki, T., Uchida, K., Tsuchiya, K., Hattori, M., & Nitta, K. (2012). Rituximab treatment for adult patients with focal segmental glomerulosclerosis. Internal Medicine (Tokyo, Japan), 51(7), 759–762. https://doi.org/10.2169/internalmedicine.51.6854

Chicago

Ochi, Ayami, Takashi Takei, Kayu Nakayama, Chihiro Iwasaki, Daigo Kamei, Yuki Tsuruta, Ari Shimizu, et al. 2012. “Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis.” Internal Medicine (Tokyo, Japan) 51 (7): 759–62. doi:10.2169/internalmedicine.51.6854.